The significant overlap highlights the dual roles of genes such as TOP2A, CCNB2, BUB1, TPX2, and EZH2 in both tumor initiation and tumor progression, reinforcing their potential as key biomarkers for PCa. This evidence concerns the gene EZH2 and posterior cortical atrophy.